David D. Meek - 15 May 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
15 May 2024
Net transactions value
$0
Form type
4
Filing time
16 May 2024, 17:40:08 UTC
Previous filing
16 Oct 2023
Next filing
04 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Award $0 +15,618 $0.000000 15,618 15 May 2024 Common Stock 15,618 $26.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option represents a right to purchase a total of 15,618 shares of the Issuer's common stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date.